First Trust Advisors LP Arvinas, Inc. Transaction History

First Trust Advisors LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$24.46 - $40.4 $2.55 Million - $4.21 Million	-104,213 Reduced 74.8%	35,100 $934,000
Q1 2024 May 13, 2024	BUY	$36.38 - $52.31 $5.07 Million - $7.29 Million	139,313 New	139,313 $5.75 Million
Q4 2022 Feb 09, 2023	BUY	$32.47 - $57.24 $768,175 - $1.35 Million	23,658 New	23,658 $809,000
Q2 2022 Aug 12, 2022	BUY	$36.01 - $74.24 $289,268 - $596,369	8,033 New	8,033 $338,000
Q1 2022 May 13, 2022	SELL	$60.27 - $81.57 $2.22 Million - $3.01 Million	-36,893 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$65.85 - $96.21 $1.08 Million - $1.58 Million	16,473 Added 80.67%	36,893 $3.03 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $1.49 Million - $2.2 Million	20,420 New	20,420 $1.68 Million
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $2.61 Million - $3.63 Million	-43,109 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$58.19 - $91.37 $1.85 Million - $2.91 Million	31,839 Added 282.51%	43,109 $2.85 Million
Q4 2020 Feb 02, 2021	SELL	$20.19 - $84.93 $323,524 - $1.36 Million	-16,024 Reduced 58.71%	11,270 $957,000
Q3 2020 Nov 05, 2020	SELL	$22.99 - $36.34 $395,979 - $625,920	-17,224 Reduced 38.69%	27,294 $644,000
Q2 2020 Jul 22, 2020	BUY	$29.88 - $56.74 $437,174 - $830,162	14,631 Added 48.95%	44,518 $1.49 Million
Q1 2020 May 06, 2020	BUY	$33.0 - $54.5 $986,271 - $1.63 Million	29,887 New	29,887 $1.2 Million

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.